197 related articles for article (PubMed ID: 2081487)
21. In vitro characterization of the cytochrome P450 isoforms involved in the metabolism of 6-methoxy-2-napthylacetic acid, an active metabolite of the prodrug nabumetone.
Matsumoto K; Nemoto E; Hasegawa T; Akimoto M; Sugibayashi K
Biol Pharm Bull; 2011; 34(5):734-9. PubMed ID: 21532165
[TBL] [Abstract][Full Text] [Related]
22. Non-steroidal anti-inflammatory drugs and renal response to exercise: a comparison of indomethacin and nabumetone.
Olsen NV; Jensen NG; Hansen JM; Christensen NJ; Fogh-Andersen N; Kanstrup IL
Clin Sci (Lond); 1999 Oct; 97(4):457-65. PubMed ID: 10491346
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of PG production by MDL 035, a new non-steroidal non-acidic anti-inflammatory compound, in rat gastric mucosa and inflammatory exudate.
Luzzani F; Colombo G; Schiatti P; Selva D; Glässer A
Pharmacol Res Commun; 1984 Aug; 16(8):755-63. PubMed ID: 6333688
[TBL] [Abstract][Full Text] [Related]
24. Different effects of indomethacin and nabumetone on prostaglandin-mediated gastric responses to central vagal activation in rats.
Cardin S; Soll AH; Taché Y
J Pharmacol Exp Ther; 1995 Nov; 275(2):667-73. PubMed ID: 7473153
[TBL] [Abstract][Full Text] [Related]
25. The effect of nabumetone and indomethacin on gastric mucosal function.
Shorrock CJ; Rees WD
J Rheumatol Suppl; 1992 Nov; 36():85-8. PubMed ID: 1474543
[No Abstract] [Full Text] [Related]
26. Ulcerogenicity and effect on inhibition of prostaglandin generation of indometacin farnesil, a prodrug of indomethacin, in rat gastric mucosa: comparison with indomethacin or loxoprofen.
Arakawa T; Fukuda T; Nakagawa K; Higuchi K; Watanabe T; Tominaga K; Kobayashi K
Drugs Exp Clin Res; 1995; 21(3):85-8. PubMed ID: 7555616
[TBL] [Abstract][Full Text] [Related]
27. Effects of nabumetone compared with naproxen on platelet aggregation in patients with rheumatoid arthritis.
Knijff-Dutmer EA; Martens A; vd Laar MA
Ann Rheum Dis; 1999 Apr; 58(4):257-9. PubMed ID: 10364907
[TBL] [Abstract][Full Text] [Related]
28. Ethanesulfohydroxamic acid ester prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs): synthesis, nitric oxide and nitroxyl release, cyclooxygenase inhibition, anti-inflammatory, and ulcerogenicity index studies.
Huang Z; Velázquez CA; Abdellatif KR; Chowdhury MA; Reisz JA; DuMond JF; King SB; Knaus EE
J Med Chem; 2011 Mar; 54(5):1356-64. PubMed ID: 21280601
[TBL] [Abstract][Full Text] [Related]
29. Comparative effects of nabumetone, naproxen, piroxicam, and diclofenac on rat gastric irritancy following acute exposure to OTC non-steroidal anti-inflammatory agents and other gastric irritants.
Carryl OR; Spangler RS
Scand J Rheumatol; 1995; 24(6):336-41. PubMed ID: 8610216
[TBL] [Abstract][Full Text] [Related]
30. Effects of NSAIDs on cryoprobe-induced gastric ulcer healing in rats.
Tibble J; Sigthorsson G; Caldwell C; Palmer RH; Bjarnason I
Aliment Pharmacol Ther; 2001 Dec; 15(12):2001-8. PubMed ID: 11736732
[TBL] [Abstract][Full Text] [Related]
31. Role of prostaglandin and thromboxane biosynthesis in gastric necrosis produced by taurocholate and ethanol.
Konturek SJ; Brzozowski T; Piastucki I; Radecki T; Dembińska-Kieć A
Dig Dis Sci; 1983 Feb; 28(2):154-60. PubMed ID: 6337793
[TBL] [Abstract][Full Text] [Related]
32. [Properties and features of nabumetone].
Davies NM; McLachlan AJ
Drugs; 2000; 59 Spec No 1():25-33. PubMed ID: 10841070
[TBL] [Abstract][Full Text] [Related]
33. Preclinical overview of nabumetone. Pharmacology, bioavailability, metabolism, and toxicology.
Mangan FR; Flack JD; Jackson D
Am J Med; 1987 Oct; 83(4B):6-10. PubMed ID: 3688000
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of prostanoid synthesis by human gastric mucosa.
Tavares IA; Collins PO; Bennett A
Aliment Pharmacol Ther; 1987 Dec; 1(6):617-25. PubMed ID: 2979689
[TBL] [Abstract][Full Text] [Related]
35. Effects of non-steroidal anti-inflammatory drugs on the in vivo synthesis of thromboxane and prostacyclin in humans.
Drvota V; Vesterqvist O; Gréen K
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():153-6. PubMed ID: 1825533
[TBL] [Abstract][Full Text] [Related]
36. Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man.
Bjarnason I; Fehilly B; Smethurst P; Menzies IS; Levi AJ
Gut; 1991 Mar; 32(3):275-7. PubMed ID: 1901563
[TBL] [Abstract][Full Text] [Related]
37. Gastric-sparing nitric oxide-releasable 'true' prodrugs of aspirin and naproxen.
Gund M; Gaikwad P; Borhade N; Burhan A; Desai DC; Sharma A; Dhiman M; Patil M; Sheikh J; Thakre G; Tipparam SG; Sharma S; Nemmani KVS; Satyam A
Bioorg Med Chem Lett; 2014 Dec; 24(24):5587-5592. PubMed ID: 25466180
[TBL] [Abstract][Full Text] [Related]
38. A novel injection strategy of flurbiprofen axetil by inhibiting protein binding with 6-methoxy-2-naphthylacetic acid.
Ogata K; Takamura N; Tokunaga J; Ikeda T; Setoguchi N; Tanda K; Yamasaki T; Nishio T; Kawai K
Eur J Drug Metab Pharmacokinet; 2016 Apr; 41(2):179-86. PubMed ID: 25537338
[TBL] [Abstract][Full Text] [Related]
39. Gastroduodenal tolerability of nabumetone versus naproxen in the treatment of rheumatic patients.
Bianchi Porro G; Montrone F; Petrillo M; Caruso I; Imbesi V
Am J Gastroenterol; 1995 Sep; 90(9):1485-8. PubMed ID: 7661175
[TBL] [Abstract][Full Text] [Related]
40. Interaction of indomethacin and naproxen with gastric surface-active phospholipids: a possible mechanism for the gastric toxicity of nonsteroidal anti-inflammatory drugs (NSAIDs).
Giraud MN; Motta C; Romero JJ; Bommelaer G; Lichtenberger LM
Biochem Pharmacol; 1999 Feb; 57(3):247-54. PubMed ID: 9890551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
